Millennium Pharmaceuticals Inc withdraws offer for AnorMED Inc


CANADA - Millennium Pharmaceuticals Inc withdrew its agreement to acquire all the outstanding common stock of AnorMED Inc (AM), a biopharmaceutical company, for ##.# Canadian dollars ($## US) in cash per share, or a total value of C$###.###

Deal Information

Credit & Investment Research

Market Research

News

Millennium Pharmaceuticals Inc Mergers & Acquisitions

Mahogany Acquisition Corp launches a tender offer for Millennium Pharmaceuticals Inc (5/14/2008 12:00:00 AM)
Gene Logic Inc acquires Millennium Pharma-Tech Program from Millennium Pharmaceuticals Inc (7/23/2004 12:00:00 AM)
Millennium Pharmaceuticals Inc acquires COR Therapeutics Inc from Takeda Pharmaceutical Co Ltd (2/12/2002 12:00:00 AM)
Signature Bioscience Inc acquires Cambridge Discovery Chemistry from Millennium Pharmaceuticals Inc (7/16/2001 12:00:00 AM)
Abbott Laboratories Inc acquires a minority stake in Millennium Pharmaceuticals Inc (pending) (3/13/2001 12:00:00 AM)
Aventis Pharmaceuticals Inc acquires a minority stake in Millennium Pharmaceuticals Inc (7/28/2000 12:00:00 AM)
Millennium Pharmaceuticals Inc acquires a minority stake in Cambridge Drug Discovery Ltd (7/27/2000 12:00:00 AM)
Millennium Pharmaceuticals Inc acquires a minority stake in Prolysis Ltd (7/27/2000 12:00:00 AM)
Millennium Pharmaceuticals Inc acquires Cambridge Discovery Chemistry from OM 2000 PLC (7/27/2000 12:00:00 AM)
Millennium Pharmaceuticals Inc acquires remaining interest in Millennium Predictive Medicine (7/18/2000 12:00:00 AM)
More..

AnorMED Inc Mergers & Acquisitions

Genzyme Corp launches a tender offer for AnorMED Inc (11/7/2006 12:00:00 AM)
Shire Pharmaceuticals Grp PLC acquires AnorMED-Fosrenol Global Patent from AnorMED Inc (3/23/2004 12:00:00 AM)
Johnson Matthey PLC acquires a minority stake in AnorMED Inc (pending) (7/1/1996 12:00:00 AM)
More..